InTouch magazine, a sister publication of ONCOLOGY and Oncology News International, has been selected by the National Library of Medicine to be indexed and included in Index Medicus and Medline. InTouch is published by PRR for cancer patients and their families.
InTouch magazine, a sister publicationof ONCOLOGY and Oncology News International, has been selected by the NationalLibrary of Medicine to be indexed and included in Index Medicus and Medline. InTouch is published by PRR for cancer patients and their families.
"It’s a real tribute to the editorial quality of InTouch," said Steven T. Rosen, MD. Dr. Rosen, director of the Robert H.Lurie Comprehensive Cancer Center, serves as medical editor-in-chief for InTouch,which just celebrated its third year of publication.
The National Library of Medicine looks to an advisorycommitteethe Literature Selection Technical Review Committeeto choosejournals and other publications for citation. Composed of authoritiesknowledgeable in the field of biomedicine, the committee includes physicians,researchers, educators, editors, health science librarians, and historians whoreview and recommend titles for indexing. The databases in the Medlars system inwhich InTouch will appear are Index Medicus and Medline. These databases areavailable online internationally.
"We’re delighted that the NLM has recognized the integrity and valueof the information in InTouch," said Dr. Rosen. "Their endorsementfurthers our mission, which is to give patients and their loved ones the mostauthoritative and up-to-date information on cancer prevention and treatment sothat they can be better informed about their health care."
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.